(S)-(+)-3-Quinuclidinol CAS 34583-34-1 Puritas ≥99.0% Factory High Quality

Description:

Nomen chemicum: (S)-(+)-3-Quinuclidinol

CAS: 34583-34-1

Aspectus: Off-White ad Alba Crystalline pulveris

Puritas: ≥99.0%

Intenta: 98.0%~ 102.0% (in Anhydrous Basis)

Medium API (CAS: 242478-38-2) in curatione vesicae Overactive (Pollakiuria)

Enquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum (S)-(+)-3-Quinuclidinol
Synonyma (S) -Quinuclidin-3-ol
CAS Number 34583-34-1
CATTUS Number RF-CC118
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C7H13NO
M. Pondus 127.18
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Off-White ad Alba Crystalline pulveris
Lepidium sativum IR Conformat Reference Imaginis
Imprimis Rotationes [α]D20 44.0°±2.0°
Damnum de Siccatio ≤0.50%
Puritas ≥99.0%
Assay 98.0%~ 102.0% (in Anhydrous Basis)
Test Standard Enterprise Standard
Consuetudinem Chiral Compositions;Pharmaceutical intermedia

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine & humore

commoda:

1

FAQ:

2

Applicatio:

Shanghai Ruifu Chemical Co., Ltd. est primarium fabricae et supplementi (S)-(+)-3-Quinuclidinoli (CAS: 34583-34-1) cum qualitate magna, late in synthesi intermediorum pharmaceuticorum et activum medicamentum pharmaceuticum. (API).(S)-(+)-3-Quinuclidinolmedium est in synthesi API (CAS: 242478-38-2).(CAS: 242478-38-2) medicamentum antimuscarinicum est quod vesicae overactivae tractandae causa signa frequentiae, necessitatis vel incontinentiae adhibetur.Receptor muscarinicus M3 est adversarius qui elaboratus est et emissus ad tractationem vesicae overactivae (pollakiuria) in Europa.M3 receptores in musculi contractiones vesicae lenis fere evocatis implicatae sunt, et receptores M2 etiam suspecti sunt ludi partes ob dominatum in musculo detrusore.

Epistulam tuam hic scribe et mitte nobis